Notes
Exact country of occurrence, reporter country and primary source country not stated.
Reference
Shin SY, et al. THE EFFICACY AND SAFETY OF ADALIMUMAB FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS AND PREDICTORS OF RESPONSE IN KOREA. Gastroenterology 158 (Suppl. 1): S-1206 abstr. Tu1890, No. 6, May 2020. Available from: URL: http://doi.org/10.1016/S0016-5085%2820%2933677-5 [abstract]
Rights and permissions
About this article
Cite this article
Adalimumab. Reactions Weekly 1813, 13 (2020). https://doi.org/10.1007/s40278-020-80770-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-80770-0